Home
/ Enseval
/ Competitors

Enseval Competitors and Similar CompaniesClear all

Enseval's competitors and similar companies include Shandong Buchang Pharmaceuticals, Harman Finochem, CVS Caremark and Y.S.P. SOUTHEAST ASIA HOLDING.

	Enseval Enseval is a healthcare product distributor.	Shandong Buchang Pharmaceuticals Shandong Buchang Pharmaceuticals (山东步长制药股份有限公司) is a company that specializes in medicine and pharmacy.	Harman Finochem Harman Finochem is a provider of medicinal products.	CVS Caremark CVS Caremark is a company that provides pharmacy healthcare solutions.	Y.S.P. SOUTHEAST ASIA HOLDING Y.S.P. Southeast Asia Holding is a company that manufactures pharmaceutical products.
Founding Date	Founding Date 1973	Founding Date 1993	Founding Date 1983	Founding Date 1979	Founding Date 1987
Type	Type Private	Type Public	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharma pharmacy	Tags Healthcare pharmacy	Tags Healthcare pharma pharmacy
Locations	Locations Jakarta, ID HQ	Locations Xi'an, CN HQ	Locations Mumbai, IN HQ	Locations Woonsocket, US HQ Lee's Summit, US	Locations Kuala Lumpur, MY HQ
Employees	Employees 2,6001% increase	Employees 7,689	Employees 1,2042% increase	Employees 3,8581% increase	Employees 1,380
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥11.7b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) RM365.1m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥4.4b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods RM172.4m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ¥7.3b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit RM196.7m (FY, 2025)
Net income	Net income N/A	Net income ¥192.3m (FY, 2025)	Net income N/A	Net income N/A	Net income RM25.2m (FY, 2025)